KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 126 filers reported holding KALA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $9,010,000 | -68.9% | 3,438,998 | -37.1% | 0.10% | -66.2% |
Q2 2021 | $28,965,000 | -21.4% | 5,465,030 | 0.0% | 0.29% | -14.8% |
Q1 2021 | $36,834,000 | -0.6% | 5,465,030 | 0.0% | 0.34% | +6.2% |
Q4 2020 | $37,053,000 | -9.6% | 5,465,030 | 0.0% | 0.32% | -37.1% |
Q3 2020 | $40,988,000 | -27.8% | 5,465,030 | +1.2% | 0.52% | -35.5% |
Q2 2020 | $56,783,000 | +19.6% | 5,402,730 | 0.0% | 0.80% | +0.1% |
Q1 2020 | $47,490,000 | +273.3% | 5,402,730 | +56.7% | 0.80% | +338.5% |
Q4 2019 | $12,723,000 | -3.0% | 3,447,840 | 0.0% | 0.18% | -26.9% |
Q3 2019 | $13,119,000 | -40.4% | 3,447,840 | 0.0% | 0.25% | -27.0% |
Q2 2019 | $21,997,000 | -22.9% | 3,447,840 | 0.0% | 0.34% | -22.7% |
Q1 2019 | $28,514,000 | +69.1% | 3,447,840 | 0.0% | 0.44% | +41.3% |
Q4 2018 | $16,860,000 | -50.5% | 3,447,840 | 0.0% | 0.31% | -23.9% |
Q3 2018 | $34,030,000 | -28.1% | 3,447,840 | 0.0% | 0.41% | -27.4% |
Q2 2018 | $47,339,000 | -13.3% | 3,447,840 | 0.0% | 0.56% | -16.5% |
Q1 2018 | $54,579,000 | +24.3% | 3,447,840 | +45.2% | 0.68% | +21.8% |
Q4 2017 | $43,919,000 | -19.0% | 2,375,279 | 0.0% | 0.56% | +7.3% |
Q3 2017 | $54,251,000 | – | 2,375,279 | – | 0.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parallel Advisors, LLC | 1 | $9 | 0.00% |